• Profound Medical Corp PRN.TO reported a quarterly adjusted loss of 36 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -26 cents. The mean expectation of four analysts for the quarter was for a loss of 29 cents per share. Wall Street expected results to range from -31 cents to -26 cents per share.

• Revenue rose 37.2% to $2.62 million from a year ago; analysts expected $3.10 million.

• Profound Medical Corp's reported EPS for the quarter was a loss of 36 cents​.

• The company reported a quarterly loss of $10.72 million.

• Profound Medical Corp shares had fallen by 17.4% this quarter and lost 36.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 3.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "strong buy"

• Wall Street's median 12-month price target for Profound Medical Corp is $11.75

This summary was machine generated from LSEG data May 9 at 01:35 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)